Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q2 2024

European Healthtech startup funding raised during Q2 2024.

In Q2 2024, 99 European Healthtech companies closed 99 funding rounds and raised €1.3B in equity funding (excluding debt and grants), up 1.1% versus Q2 2023. Debt rounds added €19M. UK led by capital raised, and Elaia was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.3B
+1.1% vs Q2 2023 · excl. debt & grants · +€19M debt
Funding rounds
99
-25.0% vs Q2 2023
Companies
99
Top country
UK
Rank among sectors
#7
6.5% of sector funding
Debt financing
€19M
1.4% of total
Top-10 round share
68.1%
of disclosed capital
Rounds ≥ €100M
1

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q2 2024 — interactive chart.
Data table
FundingRounds
Apr€257M36
May€862M36
Jun€214M27

Top countries

by € raised
Healthtech — top countries by capital, Q2 2024 — interactive chart.
Data table
Healthtech — top countries by capital, Q2 2024
UK€728M
Switzerland€184M
Germany€126M
France€100M
Sweden€53M
Finland€37M
Netherlands€27M
Spain€21M

Stage mix

by € raised
Healthtech — stage mix, Q2 2024 — interactive chart.
Data table
Healthtech — stage mix, Q2 2024
Other€833M
Series B€207M
Series C€138M
Seed€78M
Series A€50M
Debt€19M
Grant€4.2M
Pre-Seed€3.4M

Exits & M&A

10 Acquisition · 2 Merger

12 exits · €86M disclosed.

SonioAcquisitionMay 2024€86M

Top deals

largest disclosed rounds in Q2 2024
CompanyStageDateAmount
Bicycle TherapeuticsOtherMay 2024€512M
iOncturaSeries BJun 2024€80M
OculisOtherApr 2024€55M
Natural CyclesSeries CMay 2024€51M
UromemsSeries CJun 2024€44M
Grey Wolf TherapeuticsSeries BMay 2024€42M
LabGeniusOtherMay 2024€41M
EniferSeries BMay 2024€36M
ResilienceOtherMay 2024€23M
Smart ReportingSeries CApr 2024€23M
BiofidelityOtherApr 2024€22M
Memo TherapeuticsSeries CMay 2024€20M
VitestroOtherApr 2024€20M
Cn Bio InnovationsSeries BApr 2024€20M
InsempraSeries AMay 2024€19M

Top investors

most active in Q2 2024, by deal count